Atea Pharmaceuticals(AVIR) - 2021 Q4 - Earnings Call Transcript

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2021 Earnings Conference Call February 28, 2022 4:30 PM ET Company Participants Jonae Barnes - SVP, IR and Corporate Communications Jean-Pierre Sommadossi - Founder and CEO Janet Hammond - Chief Development Officer Andrea Corcoran - CFO and EVP, Legal John Vavricka - Chief Commercial Officer Conference Call Participants Matthew Harrison - Morgan Stanley Lachlan Hanbury-Brown - William Blair Roanna Ruiz - SVB Leerink Operator Good afternoon, ladies and gentlemen we ...